The company said the average rate per contract remained consistent in 2024 when compared with 2023. It explained that the increase in the fee structure that went into effect on February 1, 2024 was offset by higher member trading as a percentage of total volume and the tiered volume pricing structure.

10-KAnnual reportFiled Feb 27, 2025Period of report Dec 31, 2024Summary published (UTC) Oct 11, 2026

Key points

AI summary

The company said the average rate per contract remained consistent in 2024 when compared with 2023. It explained that the increase in the fee structure that went into effect on February 1, 2024 was offset by higher member trading as a percentage of total volume and the tiered volume pricing structure.
The company said total clearing and transaction fees revenue in 2024 included $276.7 million of transaction fees attributable to the cash markets business, compared with $284.7 million in 2023. This revenue primarily includes transaction fees from BrokerTec's fixed income volume and EBS foreign exchange volume.
CME Group said operating expenses increased by $55.4 million in 2024 when compared with 2023. The company cited as factors the increase in expenses related to technology support services driven by higher software license fees and third-party services to support the ongoing Google Cloud transformation project, higher license fees, and an increase in headcount.
The company said the board of directors approved in December 2024 a share repurchase program authorizing it to repurchase up to $3.0 billion of CME Group Class A common stock at prevailing market prices, and as of December 31, 2024 there have been no shares repurchased under this program. CME Group declared a regular quarterly dividend of $1.25 per share on February 6, 2025, and an additional annual variable dividend of $5.80 per share declared on January 16, 2025.

Key figures

Fiscal year ended December 31, 2024

Revenue: $6.1B
Operating income: $3.9B
Net income: $3.5B
EPS: $9.67
Operating cash flow: $3.7B

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Average rate per contract remains consistent despite fee increase

The company said the average rate per contract remained consistent in 2024 when compared with 2023. It explained that the increase in the fee structure that went into effect on February 1, 2024 was offset by higher member trading as a percentage of total volume and the tiered volume pricing structure.

Source · Based on the MD&A text of the filing

Cash markets business transaction fees

The company said total clearing and transaction fees revenue in 2024 included $276.7 million of transaction fees attributable to the cash markets business, compared with $284.7 million in 2023. This revenue primarily includes transaction fees from BrokerTec's fixed income volume and EBS foreign exchange volume.

Source · Based on the MD&A text of the filing

2024 operating expense increase and company explanation

CME Group said operating expenses increased by $55.4 million in 2024 when compared with 2023. The company cited as factors the increase in expenses related to technology support services driven by higher software license fees and third-party services to support the ongoing Google Cloud transformation project, higher license fees, and an increase in headcount.

Source · Based on the MD&A text of the filing

Shareholder returns: share repurchase authorization and dividends

The company said the board of directors approved in December 2024 a share repurchase program authorizing it to repurchase up to $3.0 billion of CME Group Class A common stock at prevailing market prices, and as of December 31, 2024 there have been no shares repurchased under this program. CME Group declared a regular quarterly dividend of $1.25 per share on February 6, 2025, and an additional annual variable dividend of $5.80 per share declared on January 16, 2025.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.